-Esperion - Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023

Media coverage

• Title	-Esperion - Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023
  Media name/outlet	M2 PressWIRE
  Country/Territory	United States
  Date	13/11/23
  Persons	Valentin Fuster

• Title	-Esperion - Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023
  Media name/outlet	ENP Newswire
  Country/Territory	United Kingdom
  Date	13/11/23
  Persons	Valentin Fuster

• Title	Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023
  Media name/outlet	Market News Publishing
  Country/Territory	United States
  Date	13/11/23
  Persons	Valentin Fuster

• Title	Esperion Therapeutics, Inc.: Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023
  Media name/outlet	FinanzNachrichten.de
  Country/Territory	Germany
  Date	11/11/23
  URL	ct.moreover.com/?a=52318112898&p=1gw&v=1&x=7osopfpfdgrmx7a0U2GZaA
  Persons	Valentin Fuster